Endovascular Stenting Is Rarely Necessary for the Management of Blunt Cerebrovascular Injuries

Abstract

Antithrombotic treatment for BCVI is effective for stroke prevention. Routine stenting entails increased costs and potential risk for stroke, and does not appear to provide additional benefit. Intravascular stents should be reserved for the rare patient with symptomatology or a markedly enlarging pseudoaneurysm.